Mayo Clinic Labs @Work: Vanessa Gonzalez Casar - Insights
As a hospital account executive for Mayo Clinic Laboratories, Vanessa Gonzalez Casar supports and partners with local hospitals to ensure their patients receive the right test at the right time.
Mayo Clinic Labs @Work: Sherri Hawkins - Insights
With nearly 30 years at Mayo Clinic, Sherri Hawkins has served in a wide range of laboratory-related roles. Beginning as a laboratorian on the bench and now serving as Group Purchasing Organization (GPO) manager, Sherri has been able to...
Register Now: 24th International Surgical Pathology Symposium - Insights
The 24th International Surgical Pathology Symposium is an exciting opportunity for practicing surgical pathologists to expand their knowledge and skills. Presented by Mayo Clinic Laboratories, this four-day conference will address common...
Drawing the Line: The Rationale Behind Blood Tube Collection Order - Insights
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., speaks with Brooke Katzman, Ph.D., to discuss the blood tube collection order.
Microsoft outage causing shipping disruptions - Insights
Mayo Clinic Laboratories is aware of the Microsoft outage that is impacting domestic and international shipments. We are actively monitoring the situation and making carrier adjustments as needed
Novel panel identifies toxins linked to asthma and GI diseases - Insights
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...
Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D. - Insights
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost...
Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of...